Cerebral is defending their practices. But at the same time, they just got rid of their ceo and ended a lot of their practices around eight h d and controlled substances. So if they're not prescribing these controlled substances, how much of their business remains intact? A significant part of what the company does is also so prescribe s s r is for depression, for instance. They'll, they'll prescribe non controlled substances for depression, anxiety, insomnia. These are all, uh, large components of of their business, and a the majority really.
The mental health startup Cerebral benefited from pandemic-era changes to federal telehealth laws. But its easy-to-get prescriptions for tightly regulated stimulants — heavily promoted on social media — have sparked a Department of Justice investigation.
This episode was produced by Tori Dominguez, edited by Matt Collette, fact-checked by Laura Bullard, engineered by Paul Mounsey, and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices